罗氏控股提交RO7445482注射液临床申请，为1类暂未确定治疗领域药物

七印授权

60HH6IGVIZXMH9G9W9W3141RSK2HMYZD2EMAPP6UE8ZHZJX1D8

2023-01-25 21:16:47

article

350EAB7E52798D89C6CAAFD41A6C26896EC6DFEFB665BB72B6649C4C4FCF6374

zh-CN

4923CFCD2C90249044AAB7420DC1644D9EAE543A

13998406

02636d79fc7c7cc37b9cb348037eec28743d030e5d570d0d69837a3587bed31880

8fe4d124ed111ae7f2cb93388997b3d94263497b3e6424e9dc205c4a961cdc541b78e5304c0361a994eb939e5736601ecf41203ce2d7642ec84e8d388fde6db51b

{"parameters":{"adaptation":"n","price":"100000"},"type":"cm"}

yuanben_63d19c3f1bd654.22549375

原本认证

https://www.yuanben.io/article/653db308-67ab-4352-9632-1b75807c71af

{"author":"每日经济新闻","authorization_pub_key":"03040cbbeae1adf91c3efd7306d09c6005403a041f9b7405dac489d4f8126fef8c"}